Calpro AS
私たちについて
Calpro is a leading Norwegian biotech company dedicated to advancing diagnostics and prognostics through Calprotectin, a key biomarker for intestinal inflammation. We recently merged with Creonate (UK) and are proud to be part of the EkteDx Group, strengthening our global reach and innovation capabilities.
Our products are distributed worldwide, and we are actively seeking new distribution partners to join us on our market expansion journey. Together, we aim to make proactive monitoring and precision diagnostics accessible to patients everywhere.
What we do:
– Develop unique diagnostic and prognostic solutions for auto immune disease and IBD marketed internationally
– Well established biomarker Calprotectin
私たちの価値観
Innovation – We continuously advance Calprotectin diagnostics through research and technology.
Quality – We deliver reliable, scientifically validated products that healthcare professionals trust.
Collaboration – We work closely with partners, distributors, and clinicians to improve patient care.
Integrity – We operate with transparency and responsibility in every market we serve.
Customer Focus – We prioritize the needs of healthcare providers and patients in everything we do.